280 related articles for article (PubMed ID: 32354749)
21. Quantitative CSF IgG measurements in multiple sclerosis and other neurologic diseases. An update.
Caroscio JT; Kochwa S; Sacks H; Cohen JA; Yahr MD
Arch Neurol; 1983 Jul; 40(7):409-13. PubMed ID: 6860176
[TBL] [Abstract][Full Text] [Related]
22. Neurosarcoidosis without systemic sarcoidosis.
Sommer N; Weller M; Petersen D; Wiethölter H; Dichgans J
Eur Arch Psychiatry Clin Neurosci; 1991; 240(6):334-8. PubMed ID: 1652287
[TBL] [Abstract][Full Text] [Related]
23. Angiotensin converting enzyme in cerebrospinal fluid: a new assay.
Oksanen V; Fyhrquist F; Somer H; Grönhagen-Riska C
Neurology; 1985 Aug; 35(8):1220-3. PubMed ID: 2991815
[TBL] [Abstract][Full Text] [Related]
24. Pattern and concentration of IgG in cerebrospinal fluid in neurosarcoidosis.
Scott TF; Seay AR; Goust JM
Neurology; 1989 Dec; 39(12):1637-9. PubMed ID: 2586781
[TBL] [Abstract][Full Text] [Related]
25. BAFF Index and CXCL13 levels in the cerebrospinal fluid associate respectively with intrathecal IgG synthesis and cortical atrophy in multiple sclerosis at clinical onset.
Puthenparampil M; Federle L; Miante S; Zito A; Toffanin E; Ruggero S; Ermani M; Pravato S; Poggiali D; Perini P; Rinaldi F; Gallo P
J Neuroinflammation; 2017 Jan; 14(1):11. PubMed ID: 28095856
[TBL] [Abstract][Full Text] [Related]
26. CSF characteristics in early-onset multiple sclerosis.
Pohl D; Rostasy K; Reiber H; Hanefeld F
Neurology; 2004 Nov; 63(10):1966-7. PubMed ID: 15557527
[TBL] [Abstract][Full Text] [Related]
27. Cerebrospinal fluid CXCL13 in clinically isolated syndrome patients: Association with oligoclonal IgM bands and prediction of Multiple Sclerosis diagnosis.
Ferraro D; Galli V; Vitetta F; Simone AM; Bedin R; Del Giovane C; Morselli F; Filippini MM; Nichelli PF; Sola P
J Neuroimmunol; 2015 Jun; 283():64-9. PubMed ID: 26004159
[TBL] [Abstract][Full Text] [Related]
28. Differentiating neurosarcoidosis from multiple sclerosis using combined analysis of basic CSF parameters and MRZ reaction.
Vlad B; Neidhart S; Hilty M; Ziegler M; Jelcic I
Front Neurol; 2023; 14():1135392. PubMed ID: 37034091
[TBL] [Abstract][Full Text] [Related]
29. Search for biomarkers of neurosarcoidosis by proteomic analysis of cerebrospinal fluid.
Taibi L; Boursier C; Clodic G; Bolbach G; Bénéteau-Burnat B; Vaubourdolle M; Baudin B
Ann Biol Clin (Paris); 2017 Aug; 75(4):393-402. PubMed ID: 28751284
[TBL] [Abstract][Full Text] [Related]
30. Local synthesis of specific IgG in the cerebrospinal fluid of patients with neurosarcoidosis detected by antigen immunoblotting using Kveim material.
McLean BN; Mitchell DN; Thompson EJ
J Neurol Sci; 1990 Nov; 99(2-3):165-75. PubMed ID: 2086723
[TBL] [Abstract][Full Text] [Related]
31. Cerebrospinal fluid CD4
Nordström S; Andersson B; Malmeström C
Acta Neurol Scand; 2020 Nov; 142(5):480-485. PubMed ID: 32533774
[TBL] [Abstract][Full Text] [Related]
32. [A suspicious case of central neurosarcoidosis, manifesting as a progressive gait disturbance with a lesion in the central gray matter of the midbrain, accompanying an elevated level of angiotensin converting enzyme in the cerebrospinal fluid].
Ito Y; Nakazato Y; Tomioka R; Tamura N; Shimazu K
Rinsho Shinkeigaku; 2007 Aug; 47(8):512-5. PubMed ID: 17882944
[TBL] [Abstract][Full Text] [Related]
33. Effects of natalizumab on oligoclonal bands in the cerebrospinal fluid of multiple sclerosis patients: a longitudinal study.
Mancuso R; Franciotta D; Rovaris M; Caputo D; Sala A; Hernis A; Agostini S; Calvo M; Clerici M
Mult Scler; 2014 Dec; 20(14):1900-3. PubMed ID: 24948690
[TBL] [Abstract][Full Text] [Related]
34. Detection of oligoclonal free kappa chains in the absence of oligoclonal IgG in the CSF of patients with suspected multiple sclerosis.
Goffette S; Schluep M; Henry H; Duprez T; Sindic CJ
J Neurol Neurosurg Psychiatry; 2004 Feb; 75(2):308-10. PubMed ID: 14742614
[TBL] [Abstract][Full Text] [Related]
35. Soluble CSF interleukin 2 receptor as indicator of neurosarcoidosis.
Petereit HF; Reske D; Tumani H; Jarius S; Markus Leweke F; Woitalla D; Pfister HW; Rubbert A
J Neurol; 2010 Nov; 257(11):1855-63. PubMed ID: 20556411
[TBL] [Abstract][Full Text] [Related]
36. The intrathecal, polyspecific antiviral immune response in neurosarcoidosis, acute disseminated encephalomyelitis and autoimmune encephalitis compared to multiple sclerosis in a tertiary hospital cohort.
Hottenrott T; Dersch R; Berger B; Rauer S; Eckenweiler M; Huzly D; Stich O
Fluids Barriers CNS; 2015 Dec; 12():27. PubMed ID: 26652013
[TBL] [Abstract][Full Text] [Related]
37. Neurosarcoidosis as an MS Mimic: The trials and tribulations of making a diagnosis.
MacLean HJ; Abdoli M
Mult Scler Relat Disord; 2015 Sep; 4(5):414-429. PubMed ID: 26346790
[TBL] [Abstract][Full Text] [Related]
38. A comprehensive diagnostic approach in suspected neurosarcoidosis.
Berntsson SG; Elmgren A; Gudjonsson O; Grabowska A; Landtblom AM; Moraes-Fontes MF
Sci Rep; 2023 Apr; 13(1):6539. PubMed ID: 37085608
[TBL] [Abstract][Full Text] [Related]
39. Cerebrospinal Fluid Findings in 541 Patients With Clinically Isolated Syndrome and Multiple Sclerosis: A Monocentric Study.
Berek K; Bsteh G; Auer M; Di Pauli F; Zinganell A; Berger T; Deisenhammer F; Hegen H
Front Immunol; 2021; 12():675307. PubMed ID: 34220821
[TBL] [Abstract][Full Text] [Related]
40. Cerebrospinal fluid immunoglobulin abnormalities in neurosarcoidosis.
Borucki SJ; Nguyen BV; Ladoulis CT; McKendall RR
Arch Neurol; 1989 Mar; 46(3):270-3. PubMed ID: 2919980
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
